By binding to 12 key proteins, experimental drug SS-31 improves the function of the energy-producing structure inside cells.
Prostate cancer researchers and clinicians recommend reconsidering screening guidelines, saying benefits may outweigh potential harms.
26 stakeholders, including several from UW Medicine, publish analysis of effort that emerged with pandemic outbreak.
For UW Medicine patients enrolled with that health insurer, the in-network coverage benefit is slated to end Aug. 1.
UWARN will be part of emerging pandemic virus surveillance; diagnostics, therapeutics and vaccine development; and immune response studies
MAGENTA study also found no increased stress among test subjects who did not receive pre- and post-test counseling with their results.
Finding may help explain caffeinated coffee’s link to a reduced risk of melanoma. The researchers used an enzyme from plants and marsupials to distinguish the lesion.
Affected employees will maintain benefits, including health insurance, during furloughs necessitated by financial challenges from COVID-19 response.
Patients and staff at UW Medical Center participated in the international trial, which has ended. Preliminary findings were published today.
The neutralizing antibody, called S309, is on an accelerated path toward clinical trials
